Mundipharma
Mundipharma, a global pharmaceutical company headquartered in the United States, has established itself as a leader in the healthcare industry since its founding in 1952. With a strong presence in key operational regions including Europe, Asia, and Latin America, the company focuses on innovative solutions in pain management, respiratory health, and oncology. Renowned for its unique approach to drug development, Mundipharma offers a range of core products and services that address unmet medical needs. The company is particularly noted for its commitment to responsible opioid use and the development of non-opioid alternatives. Over the years, Mundipharma has achieved significant milestones, solidifying its market position as a trusted partner in healthcare, dedicated to improving patient outcomes worldwide.
DitchCarbon Score
How does Mundipharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mundipharma's score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mundipharma's reported carbon emissions
Mundipharma, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures on their emissions, it is challenging to assess their climate impact or commitments. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in initiatives that promote environmental responsibility. As of now, Mundipharma's specific climate commitments or initiatives remain unspecified, highlighting a potential area for future development in their sustainability strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mundipharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
